You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Age-Related Macular Degeneration (AMD)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Age-Related Macular Degeneration Trial (Active Comparator CT1812, Placebo Comparator)

Not yet recruiting
  • Age-Related Macular Degeneration
  • Active Comparator CT1812
  • Placebo Comparator
  • (no location specified)
Jun 5, 2023

Impact of Non-Exudative Type 1 MNV on AMD Progression

Recruiting
  • Age-Related Macular Degeneration
  • Neovascularization, Choroidal
    • Salt Lake City, Utah
      University of Utah
    Nov 15, 2023

    Dry Age-related Macular Degeneration Trial in Rome (Intravitreal injection of CB-PRP)

    Recruiting
    • Dry Age-related Macular Degeneration
    • Intravitreal injection of CB-PRP
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Jan 23, 2023

    Progression of Early Atrophic Lesions

    Not yet recruiting
    • Age-Related Macular Degeneration
    • No intervention
    • Salt Lake City, Utah
      University of Utah
    Jul 26, 2023

    Age Related Macular Degeneration (AMD) Trial in Decatur (SPIN, Non-aerobic, stretching/balance intervention Control)

    Not yet recruiting
    • Age Related Macular Degeneration (AMD)
    • SPIN
    • Non-aerobic, stretching/balance intervention Control
    • Decatur, Georgia
      Atlanta VA Medical and Rehab Center, Decatur, GA
    Jun 26, 2023

    Rehabilitating Vision Loss in Veterans With Age-Related Macular

    Not yet recruiting
    • Age-related Macular Degeneration (AMD)
    • Study-specific rehabilitation (SSR) procedures
    • Augusta, Georgia
      Charlie Norwood VA Medical Center, Augusta, GA
    Mar 10, 2023

    Dry Age-related Macular Degeneration Trial in Ann Arbor (RPESC-RPE-4W)

    Recruiting
    • Dry Age-related Macular Degeneration
    • RPESC-RPE-4W
    • Ann Arbor, Michigan
      University of Michigan Kellogg Eye Center
    Jan 27, 2023

    Macular Degeneration (AMD) Post-marketing Surveillance in Japan

    Completed
    • Macular Degeneration
    • Aflibercept(Eylea, VEGF Trap-Eye, BAY86-5321)
    • Multiple Locations, Japan
      (unnamed)
    Jan 9, 2023

    OCT Angiography in Wet AMD

    Recruiting
    • Neovascular (Wet) Age-related Macular Degeneration (AMD)
    • Optical Coherence Tomography
    • Portland, Oregon
      Casey Eye Institute, Oregon Health & Science University
    Sep 20, 2022

    Age-related Macular Degeneration Trial in Boston (Omega-3 fatty acids (fish oil), Vitamin D3, Vitamin D3 )

    Active, not recruiting
    Has Results
    • Age-related Macular Degeneration
    • Omega-3 fatty acids (fish oil)
    • +3 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 26, 2022

    Geographic Atrophy Trial (BI 771716)

    Not yet recruiting
    • Geographic Atrophy
    • BI 771716
    • (no location specified)
    Aug 29, 2023

    Age-Related Macular Degeneration, Retinitis Pigmentosa, Ultrasound Therapy; Complications Trial (Non-invasive ultrasound retinal

    Not yet recruiting
    • Age-Related Macular Degeneration
    • +2 more
    • Non-invasive ultrasound retinal stimulation Device
    • (no location specified)
    Jun 19, 2023

    Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)

    Recruiting
    • Geographic Atrophy
    • Macular Degeneration
    • Phoenix, Arizona
    • +3 more
    Mar 31, 2023

    Validation of Bulbicam for DR- and AMD-patients

    Not yet recruiting
    • Diabetic Retinopathy
    • Age-Related Macular Degeneration
    • BulbiCam
    • (no location specified)
    Jun 27, 2022

    Geographic Atrophy of the Macula, Macular Degeneration Trial in United States (AVD-104, Sham injection)

    Not yet recruiting
    • Geographic Atrophy of the Macula
    • Macular Degeneration
    • Saint Petersburg, Florida
    • +4 more
    Apr 20, 2023

    Dry Age-related Macular Degeneration Trial (QA102/Placebo, QA102, Placebo)

    Not yet recruiting
    • Dry Age-related Macular Degeneration
    • QA102/Placebo
    • +2 more
    • (no location specified)
    Sep 8, 2022

    Age-Related Macular Degeneration Trial (Bevacizumab-IRDye800CW, Vedolizumab-IRDye800CW)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • (no location specified)
    May 19, 2022

    Production of iPSC Derived RPE Cells for Transplantation in AMD

    Completed
    • Age Related Macular Degeneration (AMD)
      • (no location specified)
      Apr 4, 2022

      Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)

      Recruiting
      • Neovascular Age-related Macular Degeneration
      • Diabetic Macular Edema
      • Los Angeles, California
      • +11 more
      Jan 11, 2023

      Neovascular Age-related Macular Degeneration

      Completed
      • Age-related Macular Degeneration (AMD)
      • East Hanover, New Jersey
        Novartis Investigative Site
      Dec 15, 2021

      Age Related Macular Degeneration Trial in Indianapolis (RBM-007 Injectable Solution)

      Recruiting
      • Age Related Macular Degeneration
      • RBM-007 Injectable Solution
      • Indianapolis, Indiana
        Midwest Eye Institute
      Feb 10, 2022

      Age Related Macular Degeneration Trial in Clermont-Ferrand (T7082)

      Completed
      • Age Related Macular Degeneration
      • T7082
      • Clermont-Ferrand, France
        Wilfried Roquet
      Feb 14, 2022

      Age-related Macular Degeneration (AMD) Trial in Créteil (Dimethyl Fumarate (TECFIDERA™), No active : no treatment)

      Recruiting
      • Age-related Macular Degeneration (AMD)
      • Dimethyl Fumarate (TECFIDERA™)
      • No active : no treatment
      • Créteil, Val De Marne, France
        Centre intercommunal de Créteil
      Aug 2, 2022

      Preparation of Patient Autologous Induced Pluripotent Stem

      Not yet recruiting
      • Age-Related Macular Degeneration
      • somatic cell collection
      • (no location specified)
      Aug 14, 2023

      VeriSee AMD in Screening for Age-Related Macular Degeneration

      Completed
      • Macular Degeneration, Age Related
      • Maculopathy, Age Related
        • Taipei, Taiwan
          National Taiwan University Hospital
        Oct 23, 2022